Massachusetts, U.S. - on September 29, 2020, the industry-renowned Fierce Biotech's 2020 Fierce 15 list was released. Quralis, a platform company invested and incubated by Viva BioInnovator was included in the list. As a biotech company focused on the precise treatment of amyotrophic lateral sclerosis (ALS) and other neurological diseases, Quralis continues to promote the development of new therapies for ALS and genetically related frontotemporal dementia (FTD). Up to now, there is no effective treatment for neurodegenerative diseases on the market.
Quralis Included in the Fierce Biotech 2020 Fierce 15 List
September 29, 2020